Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed
- PMID: 20713719
- PMCID: PMC2930528
- DOI: 10.1073/pnas.1010365107
Neuropeptide receptor positive allosteric modulation in epilepsy: galanin modulation revealed
Conflict of interest statement
The author declares no conflict of interest.
Comment on
-
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal models.Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15229-34. doi: 10.1073/pnas.1008986107. Epub 2010 Jul 26. Proc Natl Acad Sci U S A. 2010. PMID: 20660766 Free PMC article.
References
-
- Hökfelt T, Bartfai T, Bloom F. Neuropeptides: Opportunities for drug discovery. Lancet Neurol. 2003;2:463–472. - PubMed
-
- Vezzani A, et al. Enhanced neuropeptide Y release in the hippocampus is associated with chronic seizure susceptibility in kainic acid treated rats. Brain Res. 1994;660:138–143. - PubMed
-
- Vezzani A, Hoyer D. Brain somatostatin: A candidate inhibitory role in seizures and epileptogenesis. Eur J Neurosci. 1999;11:3767–3776. - PubMed
-
- Noè F, et al. Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy. Brain. 2008;131:1506–1515. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
